紅豆股份(600400.SH):上海駿達完成向通產麗星轉讓力合科創9.46%股權
格隆匯12月16日丨紅豆股份(600400.SH)公佈,公司控股子公司上海紅豆駿達資產管理有限公司(簡稱“上海駿達”)擬向深圳市通產麗星股份有限公司(簡稱“通產麗星”,股票代碼:002243.SZ)轉讓持有的力合科創集團有限公司(簡稱“力合科創”)9.46%股權。
根據《深圳市通產麗星股份有限公司發行股份購買資產並募集配套資金暨關聯交易實施情況暨新增股份上市公告書》,通產麗星本次向上海駿達發行股份7562.71萬股,上述股份將於2019年12月18日上市。上海駿達本次取得的通產麗星股份自股份上市之日起12個月內不得轉讓,同時將於鎖定期屆滿後按照業績承諾實現的情況分期解鎖。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.